by: TigerPosted on:

Zimmer Biomet has partnered with RevelAi Health

Zimmer Biomet has partnered with RevelAi Health to market a new AI tool designed to help with orthopedic care, particularly for conditions like osteoarthritis. Here’s a breakdown of what they claim their generative AI tool can do:

  1. Automate Clinical Workflows: The AI tool can handle routine tasks and processes, making it easier and quicker for healthcare providers to manage their work.
  2. Support Patients: It provides personalized support to patients through instant messaging and conversational AI, which can answer questions and give guidance.
  3. Improve Patient Outcomes: By helping patients stick to their treatment plans and reducing the need for hospital readmissions, the AI tool aims to improve overall patient health outcomes.
  4. Reduce Clinician Burnout: By taking over some of the administrative and repetitive tasks, the tool aims to reduce the workload and stress on healthcare providers.
  5. Value-Based Care: The tool is designed to help healthcare providers move from charging for each service they provide to a system where they are rewarded for improving patient health, thus focusing on better overall care.
  6. Equity-Driven Approach: Zimmer Biomet and RevelAi emphasize creating a fair and comprehensive approach to care, considering socioeconomic, environmental, and behavioral factors in addition to medical needs.

In essence, Zimmer Biomet and RevelAi claim their AI tool can streamline the work of healthcare providers, offer better support to patients, and improve overall health outcomes in orthopedic care.

SHORT DEFINITION: Generative AI refers to deep-learning models that can generate high-quality text, images, and other content based on the data they were trained on.

LONG DEFINITION: Generative Artificial Intelligence (Generative AI) refers to a class of AI algorithms that are capable of generating new data that resembles a given dataset. These algorithms can create text, images, music, and other types of content by learning patterns and structures from existing data and then producing new, original outputs based on that learned information.

Generative AI includes various models and techniques, such as:

  1. Generative Adversarial Networks (GANs): These involve two neural networks, a generator and a discriminator, that compete with each other. The generator creates new data, while the discriminator evaluates it. Through this process, the generator improves its ability to produce realistic data.
  2. Variational Autoencoders (VAEs): These encode input data into a latent space and then decode it back to the original form, with the capability to generate new data points by sampling from the latent space.
  3. Transformer-based Models: These include models like GPT (Generative Pre-trained Transformer), which are particularly powerful in generating human-like text by predicting the next word in a sequence based on the context provided by previous words.

Generative AI has numerous applications, including content creation, data augmentation, image synthesis, and more, making it a significant area of research and development in the field of artificial intelligence.

Zimmer, RevelAi partner to sell AI tool for orthopedic care.

(written by Nick Paul Taylor Contributor)

RevelAi uses generative artificial intelligence to automate clinical workflows and support patients with conditions such as osteoarthritis.

Dive Brief:

  • Zimmer Biomet has partnered with RevelAi Health to market clinical software powered by generative artificial intelligence.
  • RevelAi is using AI to automate clinical workflows and support patients with conditions such as osteoarthritis. The company aims to improve patient outcomes while reducing clinician burnout.
  • Zimmer, which announced the partnership Wednesday, has struck a multi-year co-marketing agreement to sell RevelAi’s patient care management platform and care team dashboard for healthcare providers.

Dive Insight:

Zimmer is primarily an orthopedic company, with knee and hip devices accounting for around two-thirds of its sales in 2023. However, Zimmer CEO Ivan Tornos used the company’s investor day in May to set out a broader vision for the business that goes beyond selling implants. Tornos wants Zimmer to focus on solving the problems faced by patients, physicians, providers and payers. 

RevelAi, formerly Azra Care, has an overlapping objective. The company has developed software for management of fall-related fractures, osteoarthritis and other musculoskeletal conditions to improve outcomes, minimize expenses and ensure equitable access to care. RevelAi works with health systems, ambulatory surgery centers (ASCs) and payers. Zimmer sees ASCs as a growth opportunity.

Through RevelAi Care Coach, the company provides instant patient messaging and inbox management to reduce the burden on care teams. The platform uses conversational AI to provide personalized support to patients. RevelAi has also developed a care team dashboard for AI-powered triage. 

The technologies are designed to help providers transition from fee-for-service to value-based care. RevelAi is aiming to improve patient adherence to treatment, reduce readmissions, and support Centers for Medicare and Medicaid Services compliance.

Zimmer framed its interest in the software as part of its recognition that medical care is only one driver of health outcomes. Socioeconomic, environmental and behavioral factors matter too. By working with RevelAi, Zimmer wants to “create an equity-driven, whole-person approach to value-based care using integrated AI-enabled tools to enhance orthopedic care.”